Dr. Michael Täger

Dr. Michael Täger, MD, is a company shareholder and has acted as scientific advisor for the company from the beginning. He completed the majority of basic and applied research for the thiol-active cytoprotective ThioTec™ technology platform while attending the university and, subsequently, its commercial aspects at the company. Since April 2003, he serves as managing director.

For many years Dr. Täger has been active in the area of clinical and experimental medicine and, in particular, the area of clinical and experimental immunology. He is a recognized expert in the area of cytoprotection and thiol metabolism, as well as in immune cell functions, holding a “Certification for Specialized Immunodiagnostics”. As a clinician he mainly focused on special therapeutic approaches for chronic inflammatory pain.